Skip to content
Review Open access

Remodeling of the brain immune microenvironment in Alzheimer’s disease: interactions among microglia, astrocytes, complement, and the neurovascular unit

Sep 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 189 references
Medicine

TL;DR

Current evidence supports a dynamically reconfigured system rather than a uniformly escalating inflammatory response, which should move beyond broad anti-inflammatory approaches to preserve effective pathological clearance within appropriate disease windows, limit maladaptive synaptic injury, and restore glial and neurovascular homeostasis.

Abstract

Alzheimer’s disease is defined by amyloid-β deposition and tau pathology, yet comparable pathological burdens do not necessarily correspond to similar cognitive trajectories, regional patterns of injury, or treatment responses. This discordance suggests that the cellular and tissue microenvironment may materially shape disease progression. Genetic studies, single-cell and spatial omics, and human-derived models further indicate that microglia, astrocytes, the complement system, and the neurovascular unit undergo coordinated remodeling during the preclinical phase of AD and influence pathological spread, synaptic injury, and neurodegeneration through intercellular interactions. Remodeling of the brain immune microenvironment is regionally specific, stage dependent, and heterogeneous across cellular states; conventional pro-inflammatory/anti-inflammatory or activated/resting dichotomies therefore fail to capture its dynamics. This review examines the remodeling of the AD brain immune microenvironment through interactions among microglia, astrocytes, complement, and the neurovascular unit, with emphasis on their roles in Aβ and tau pathology, synaptic injury, lipid homeostasis, and vascular dysfunction, and considers the interpretive limits of single-cell and spatial-omics evidence. Current evidence supports a dynamically reconfigured system rather than a uniformly escalating inflammatory response. Therapeutic strategies should move beyond broad anti-inflammatory approaches to preserve effective pathological clearance within appropriate disease windows, limit maladaptive synaptic injury, and restore glial and neurovascular homeostasis.

Read PDF

Similar papers

Review Open access Aug 2026

Microglia-mediated neuroinflammation in Alzheimer’s disease: mechanisms and emerging therapeutic targets

A “cellular state–pathological network–therapeutic window” framework is proposed and the roles of microglia in amyloid-β plaque seeding and compaction, NLRP3 inflammasome activation, mitochondrial DNA–cGAS–STING signaling, complement-mediated synaptic engulfment, and bidirectional microglia–tau feedback are systematica...

Lian-Jing Xu, Ying Zhang, Li Jiang et al. · 0 citations
Review Open access Sep 2026

Blood–brain barrier dysfunction and peripheral immune activation in Alzheimer’s disease: an inflammation-centered review

An inflammation-centered model is proposed in which BBB breakdown and peripheral immune dysregulation form a pathogenic loop that accelerates neurodegeneration, and targeting this BBB–peripheral immune axis may provide new opportunities for biomarker development, patient stratification, and combination therapy beyond c...

Zu-Li Yang, Zhi-Qiang Xiao, Bin Huang et al. · 0 citations
Open access Aug 2026

Altered microglial communication in brains with Alzheimer’s Disease pathology

It was found that AD was characterized by altered microglial composition and rewiring of intercellular communication, including disease-specific signaling pathways and distinct interaction hubs.

Loren dos Santos, R. Vialle, Natacha Comandante-Lou et al. · 0 citations
Open access Oct 2026

Mesenchymal stromal cell-derived extracellular vesicles attenuate inflammation-associated cognitive impairment and hippocampal microglial-synaptic remodeling

Microglia are central regulators of synaptic structure and cognitive function, yet under chronic inflammatory conditions, they can adopt stress-associated states associated with neuronal and synaptic vulnerability. Although inflammation-driven cognitive decline is often attributed to synapse loss, increasing evidence...

G. Ayyubova, E. Gasimov, F. Rzayev et al. · 0 citations
Review Open access Sep 2026

Neuroinflammation and vascular pathology in Alzheimer's Disease: The NRF2/HO-1 axis as a modulator of microglial phenotypes.

It is argued that perivascular microglia represent a key "decision hub" at the neurovascular interface, where shifts from homeostatic surveillance toward disease-associated microglia (DAM) programs influence both amyloid handling and the amplification of neuroinflammation.

M. Olazabal-Chias, M. Kratochvil, A. I. Rojo · 0 citations
Review Oct 2026

Neuroimmune Dynamics of the Microglia-astrocyte Axis: Implications for Neurodegenerative Disorders as a Double-edged Sword.

INTRODUCTION Maintaining homeostasis in the Central Nervous System (CNS) requires constant, bidirectional molecular interactions between microglia and astrocytes. This intercellular communication, mediated by cytokines, extracellular vesicles, purinergic signals, and connexin hemichannels, synchronizes immune surveilla...

Dhrubajyoti Borah, Piyali Devroy, Asis Bala · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.